Influence of angiotensin II on expression of toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy

被引:34
作者
Ahn, Kyung Ohk
Lim, Sun Woo
Li, Can
Yang, Hyun Joo
Ghee, Jung Yeon
Kim, Jin Young
Kim, Su Hyun
Kim, Jin
Yang, Chul Woo
机构
[1] Catholic Univ Korea, Dept Internal Med, Xenotransplantat Res Ctr, Seoul, South Korea
[2] Catholic Univ Korea, Dept Anat, Cell Death Res Ctr, Seoul, South Korea
[3] Yanbian Univ, Coll Med, Affiliated Hosp,Nephrol & Dialysis Unit, Dept Internal Med, Yanji, Peoples R China
关键词
cyclosporine; angiotensin II; toll-like receptor; dendritic cell;
D O I
10.1097/01.tp.0000258589.39006.94
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Angiotensin (Ang) II plays an important role in immune regulation. We evaluate the influence of the renin-angiotensin system (RAS) in the innate immune response caused by cyclosporine A (CsA)-induced renal injury. Methods. Two separate studies were performed in Sprague Dawley rats. First, losartan (LSRT, 10 mg/kg per day) was concurrently administered with CsA (15 mg/kg per day) for 28 days. Second, AngII (435 ng/kg/min) was infused with or without LSRT for 14 days. Results. AngII blockade with LSRT decreased toll-like receptor (TLR) 2 mRNA and protein expression, expression of tumor necrosis factor (TNF)-alpha mRNA, and expression of major histocompatibility complex class II antigen, which was upregulated in CsA-induced renal injury. The increased number of matured dendritic cells (DCs) in CsA-induced renal injury was also decreased by concomitant treatment of LSRT. Direct infusion of AngII increased TNF-alpha mRNA, TLR2 mRNA, and protein and the number of DCs, compared with the control rat kidney. In contrast, concomitant treatment of LSRT decreased all parameters. Conclusion. AngII plays a pivotal role in activating the innate immune response in CsA-induced renal injury.
引用
收藏
页码:938 / 947
页数:10
相关论文
共 52 条
[1]  
AHMED SS, 1993, J PHARMACOL EXP THER, V265, P1047
[2]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[3]   Signaling danger:: Toll-like receptors and their potential roles in kidney disease [J].
Anders, HJ ;
Banas, B ;
Schlöndorff, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04) :854-867
[4]  
ANDOH TF, 1994, TRANSPLANTATION, V57, P483
[5]   Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses [J].
Beg, AA .
TRENDS IN IMMUNOLOGY, 2002, 23 (11) :509-512
[6]  
BENNETT WM, 1994, NEPHROL DIAL TRANSPL, V9, P141
[7]   Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[8]   PREVENTION OF EXPERIMENTAL CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS BY LOSARTAN AND ENALAPRIL [J].
BURDMANN, EA ;
ANDOH, TF ;
NAST, CC ;
EVAN, A ;
CONNORS, BA ;
COFFMAN, TM ;
LINDSLEY, J ;
BENNETT, WM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 269 (04) :F491-F499
[9]   Amelioration of cyclosporine nephrotoxicity by irbesartan, a selective AT1 receptor antagonist [J].
Chander, V ;
Singh, D ;
Tirkey, N ;
Chander, H ;
Chopra, K .
RENAL FAILURE, 2004, 26 (05) :467-477
[10]  
ELZINGA LW, 1993, J AM SOC NEPHROL, V4, P214